NASA Research Announcement (NRA): Extended Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and Chronic Exposures to Stressors
Award Notice Posted
- Solicitation number
- NNH21ZDA015N
- Agency
-
Ames Research Center
National Aeronautics and Space Administration
- Awarded
- to Brigham & Womens Hospital Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 80ARC022CA007 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AR13 Space R&D Services; Space Flight, Research And Supporting Activities; Experimental Development
- Place of performance
- Boston, Massachusetts 02115, United States
Notice details come from SAM.gov. Updated .
About this opportunity
Brigham and Women's Hospital, Inc. was awarded a $199,951.20 contract by the National Aeronautics and Space Administration Ames Research Center to conduct research on modeling anthracycline-triggered vascular dysfunction under NASA Research Announcement number NNH21ZDA015N for Extended Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and Chronic Exposures to Stressors, issued in collaboration with the National Institutes of Health, Department of Health and Human Services Biomedical Advanced Research and Development Authority, and the Food and Drug Administration to support modeling acute and chronic exposures to stressors using 3D tissues and microphysiological systems.
Notice text
Brigham And Women's Hospital, Inc. (BWH) proposal titled "Modeling Anthracycline-triggered Vascular Dysfunction" was selected as a result of NASA Research Announcement (NRA) No. NNH21ZDA015N for Extended Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and Chronic Exposures to Stressors, issued by NASA, in collaboration with the National Institutes of Health (NIH), Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA), and the Food and Drug Administration (FDA).
Awarded contract 80ARC022CA007 to BRIGHAM & WOMENS HOSPITAL INC for 1999512.00 on 2022-09-27.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity